Skip to content

DR. TOM BOGAERT

Active Private limited companyfounded 2015active for 11 yearsReek 86, 2880 BornemKBO/BCE: BE 0597.967.683
DR. TOM BOGAERT
Follow ReportCompare

Overview

Lifetime

11 annual accounts with figures on one time axis
peak €335,721 (2021)
€268,099▼ 17.4%
peak €249,254 (2021)
€197,485▼ 16.3%
peak €664,066 (2022)
€18,600▼ 96.4%
€518,050▲ 15×
peak 1 FTE (2017)
-not published
Board1 name since 2015
1 director
Documentsfilings and deeds
16-07-202615 days before the deadline
2025micro format
Gross margin from €324,687 to €268,099Dividend €693,143Equity from €514,258 to €18,600Debts from €34,784 to €518,050Cash from €253,557 to €100,607

Key points

from the 2025 annual accounts

Equity

€18,600 from €664,066 in 2022

Equity fell by 97% in 3 years.

Turnover

≈ €410,000 estimated

The micro format states no turnover.

Debts

€518,050 97% of the balance sheet
Suppliers 2%Taxes and wages 3%Other 95%

Liquidity

1.01 was 34.87 in 2024

Short-term debts rose from €15,196 to €518,050.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

Seven of the last ten came late. The 2022 accounts came latest: 30 days after the end of the period.

Position in the sector

3.5%

Lower solvency than 91% of companies in human health. Sector median 63.0% · 20,774 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 536 companies had the same profile as DR. TOM BOGAERT has now. Each dot stands for 2 companies, two years later.

95.9%
were still trading
3.4%
stopped another way
0.7%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 536 companies, not a prediction for DR. TOM BOGAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-02-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0597967683
Resignation: (manager) Reappointment: (director) · Gazette deed
Registered office moved within Bornem New registered office: Reek 86, 2880 Bornem · Previous registered office: Reek 28, 2880 Bornem · General meeting of 28-09-2017 · Gazette deed
Registered office moved from Damme to Bornem New registered office: Reek 28, 2880 Bornem · Previous registered office: Dorpsstraat 24 bus 7, 8340 Damme · General meeting of 01-10-2016 · Gazette deed
All 24 events

Comparable companies

same main activity, similar in size and age
Company
DR. TOM BOGAERT Bornem €536,650 €268,099 3.5% -
Dr. Nathalie van Meir Brasschaat €539,577 €268,636 74.6% -
Dr. Heymans Julie Balen €540,185 €252,193 34.4% -
Dr. Dominiek Despriet, oogarts Kalmthout €585,447 €282,774 35.3% -
UROLOGIEPRAKTIJK FRANSIS Brasschaat €615,647 €254,277 5.5% -
DEBLAERE ISABEL, ANESTHESIE Knokke-Heist €536,401 €273,808 24.0% -
DR. SOFIE DEPUYDT, HEELKUNDE Ostend €507,436 €285,441 54.3% -

These companies have the same main activity as DR. : specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €507,000 and €616,000, founded between 2014 and 2015.

Official details

Source: KBO
Status
Active since 13-02-2015Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.239.417.9172880 Bornem, since 13-02-2015
Financial year end
31 December
Peppol
Reachable since 09-01-2026
Company details

Annual accounts 2025

€268,099▼ 17.4%
€197,485▼ 16.3%
€18,600▼ 96.4%
€536,650▼ 2.3%
Filing
Filed on 16-07-2026, 15 days before the end of the filing period
Financials

Insights on DR. TOM BOGAERT

DR. files the micro format. That format states no turnover. The gross margin rose from €245,154 in 2015 to €268,099 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 16-07-2026, 15 days before the deadline
€268,099
▼ 17.4%
€261,546
▼ 18.0%
€197,485
▼ 16.3%
€3,460
▼ 99.3%
3.5%
▼ 90.2 percentage points
1.01
▼ 33.87

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €410,000. Estimated: probably between €360,000 and €560,000.

Balance sheet

balance sheet total €536,650 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

3.5%

Higher than 8% of 20,774 companies in 2025.

1.01

Higher than 19% of 20,348 companies in 2025.

36.8%

Higher than 72% of 20,630 companies in 2025.

DR. TOM BOGAERT Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: top quarter · Equity: bottom quarter · Balance sheet total: middle half · Working capital: bottom quarter

Staff

Staff costs divided by the average number of full-time equivalents.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015
Balance sheet: assets
20/58 536,650549,042758,291831,248663,852563,746470,584360,753455,807318,509255,917
21/28 15,14019,10413,11213,97616,98819,13526,47625,30330,48440,0953,499
22/27 15,14019,10413,11213,97616,98819,13526,47625,30330,48440,0953,499
24 11,78814,2396,6024,5774,6993,95612,20813,01417,62024,5213,499
26 3,3524,8656,5109,40012,28915,17914,26812,28912,86415,574-
29/58 521,509529,938745,179817,272646,864544,611444,108335,450425,323278,413252,419
40/41 182,94076,274106,106128,491120,89397,847108,506158,934184,269158,337192,981
40 --2501,849---1,090178--
41 182,94076,274105,856126,642120,89397,847108,506157,844184,091158,337192,981
50/53 233,515194,106156,018114,01972,12941,00014,00050,00050,00050,000-
54/58 100,607253,557474,953573,192452,035403,957321,377122,904187,22869,87859,240
490/1 4,4476,0018,1021,5701,8071,8072253,6123,827198198
Balance sheet: equity and liabilities
10/49 536,650549,042758,291831,248663,852563,746470,584360,753455,807318,509255,917
10/15 18,600514,258589,296664,066467,775218,521378,999188,070380,764268,832172,252
10/11 18,60018,60018,60018,60018,60018,60018,60018,60012,40012,40012,400
100 ------18,60018,60018,60018,60018,600
101 --------6,2006,2006,200
13 -495,600570,360644,860448,860199,860359,860168,860368,240256,240159,240
130/1 ---1,8601,8601,860-----
130 ------1,8601,8601,2401,2401,240
1311 ---1,8601,8601,860-----
133 -495,600570,360643,000447,000198,000358,000167,000367,000255,000158,000
14 -5833660631561539610124192612
17/49 518,05034,784168,995167,182196,077345,22591,585172,68375,04349,67683,665
17 -15,000146,000126,000182,000328,00077,000129,000---
178/9 -15,000146,000126,000182,000328,00077,000129,000---
42/48 518,05015,19615,24334,91414,0774,88410,46541,24575,04349,67683,665
44 10,59311,54210,00010,569---49541,572-
440/4 10,59311,54210,00010,569---49541,572-
45 14,3143,0004,13223,81613,1403,9859,69940,79274,81947,90583,151
450/3 14,3143,0004,13223,81613,1403,9859,69933,86969,65347,90583,151
454/9 -------6,9235,166--
47/48 493,1436541,111530937899767403170200514
492/3 -4,5897,7526,268-12,3424,1202,439---
Income statement
9900 268,099324,687309,783271,137335,721279,350280,403274,671199,028157,015245,154
62 -------32,53820,754--
630 5,4034,6724,3215,5715,44711,75013,75210,9589,61112,1992,025
640/8 1,1501,2291,0551,0748997778478668121,388348
9901 261,546318,786304,407264,491329,376266,822265,804230,310167,851143,428242,781
75/76B 1,074829299851309051,1938031,101522
75 1,074829299851309051,1938031,101522
65/66B 3,5009,2878,0477,2371,3278,3164,2102,5297036300
65 3,5009,2878,0477,2371,3278,3164,2102,5297036300
9903 259,121310,328296,362258,252328,561258,507262,499228,974168,584144,494243,003
67/77 61,63674,36671,13261,96079,30760,98569,97060,86956,65347,91483,151
9904 197,485235,962225,230196,292249,254197,522192,529168,106111,93296,580159,852
9905 197,485235,962225,230196,292249,254197,522192,529168,106111,93296,580159,852
Appropriation of the result
9906 197,543236,298225,836196,606249,315198,061193,139168,230112,12497,192159,852
14P 5833660631561------
791/2 495,600311,000300,000---1,600367,000---
691/2 -236,240225,500196,000249,000198,000192,600167,620112,00097,000159,240
6920 -------620--1,240
6921 -236,240225,500196,000249,000198,000192,600167,000112,00097,000158,000
694/7 693,143311,000300,000---1,600367,000---
694 693,143311,000300,000---1,600367,000---
Social balance sheet
9087 -------11--
Hours worked1013 -------1,7781,072--
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 7 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 16-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 16-07-2026 2026-00307317 PDF
31-12-2024 micro format 30-06-2025 2025-00227591 PDF
31-12-2023 micro format 29-08-2024 2024-00419267 PDF
31-12-2022 micro format 30-08-2023 2023-00413849 PDF
31-12-2021 micro format 05-08-2022 2022-20279467 PDF
31-12-2020 micro format 13-08-2021 2021-48500156 PDF
31-12-2019 micro format 21-08-2020 2020-43100515 PDF
31-12-2018 micro format 20-08-2019 2019-47800319 PDF
31-12-2017 micro format 29-08-2018 2018-52900388 PDF
31-12-2016 micro format 31-07-2017 2017-40800099 PDF
31-12-2015 abbreviated format 17-08-2016 2016-43200051 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015
266,949323,458308,727270,062334,822278,572279,556241,268177,462155,627244,806
202,887240,634229,550201,863254,700209,272206,281179,064121,542108,779161,877
1,43910,6643,4562,5593,2994,40914,9255,777048,7955,524
-152,950-221,396-98,240121,15748,07882,580198,473-64,324117,34910,638-
3,460514,742729,936782,358632,787539,727433,643294,205350,280228,737168,753
3.5%93.7%77.7%79.9%70.5%38.8%80.5%52.1%83.5%84.4%67.3%
1.0134.8748.8923.4145.95-42.448.135.675.603.02
27.850.070.290.250.421.580.240.920.200.180.49
-45.9%38.2%29.6%53.3%90.4%50.8%89.4%29.4%35.9%92.8%
36.8%43.0%29.7%23.6%37.5%35.0%40.9%46.6%24.6%30.3%62.5%
76.2834.8338.3637.31over 100------

A ratio outside any meaningful range has been withheld (balance sheet total €536,650, equity €18,600).

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€1,439€10,664€3,456€2,559€3,299
€5,403€4,672€4,321€5,571€5,447

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on DR. TOM BOGAERT

The operating result for 2025 is 18% lower than in 2024 and the lowest since 2018.

Debt's share of the balance-sheet total rises from 6.3% to 96.5%. Equity is lower and debt is higher.

Board & ownership

Board

1 director, last change in 2023
Director (not named in the articles)
since 13-02-2015 term without a fixed end
earlier manager (not named in the articles), until 08-12-2023
listed in the 2025 annual accounts, filed on 16-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 08-12-2023

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
    • Director (not named in the articles), from 13-02-2015 to date
    • Manager (not named in the articles), until 08-12-2023

See the board, name and registered office on a given date →

Control

See the annual accounts at the National Bank and the publications in the Belgian Official Gazette.

Capital

Contribution
€18,600
Source
2025 annual accounts

Articles of association

deed of 08-12-2023 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Saturday of June at 10:00

Network & group

No group

DR. has no parent and no holdings in its annual accounts. is the only director. DR. shares no director with another company.

Timeline

Timeline

24 events since 2015

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 15 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0597967683
2025
Annual accounts 2024 filed PDFmicro format · 31 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 29 days late
2023
Liquidity more than doubled current ratio 48.89 The current ratio rises from 23.41 to 48.89. Short-term debt falls from €34,914 to €15,243.
Resignation: (manager)Reappointment: (director)3 points ▸
  • Director resignation, (manager (not named in the articles))
  • Director reappointment, (director (not named in the articles))
  • Registered office clause, Reek 86, 2880 Bornem
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFmicro format · 30 days late
2022
Equity above €500,000 equity €664,066 ▲42% Equity rises from €467,775 to €664,066.
Annual accounts 2021 filed PDFmicro format · 5 days late
2021
Highest result from 2015 to 2025 net €249,254 ▲26.2% The operating result of €329,376 and the net result of €249,254 are both a record.
Annual accounts 2020 filed PDFmicro format · 13 days late
2020
Liquidity more than doubled current ratio 111.51 The current ratio rises from 42.44 to 111.51. Short-term debt falls from €10,465 to €4,884.
Annual accounts 2019 filed PDFmicro format · 21 days late
2019
Liquidity more than 5 times current ratio 42.44 The current ratio rises from 8.13 to 42.44. Short-term debt falls from €41,245 to €10,465.
Annual accounts 2018 filed PDFmicro format · 20 days late
2018
Annual accounts 2017 filed PDFmicro format · 29 days late
2017
Registered office moved within BornemNew registered office: Reek 86, 2880 Bornem · Previous registered office: Reek 28, 2880 Bornem · General meeting of 28-09-20172 points ▸
  • General meeting, 28-09-2017
  • Registered-office move, Reek 86, 2880 Bornem

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFmicro format · on the deadline day
Registered office moved from Damme to BornemNew registered office: Reek 28, 2880 Bornem · Previous registered office: Dorpsstraat 24 bus 7, 8340 Damme · General meeting of 01-10-20162 points ▸
  • General meeting, 01-10-2016
  • Registered-office move, Reek 28, 2880 Bornem

Open the deed in the Belgian Official Gazette

2016
Weakest financial year net €96,580 ▼39.6% The net result drops to €96,580, the lowest from 2015 to 2025. It recovers the following year.
Equity above €200,000 equity €268,832 ▲56.1% With a profit in every financial year since 2015, equity grows to €268,832.
Annual accounts 2015 filed PDFabbreviated format · 17 days late
2015
Incorporation PDFpublished on 17-02-2015
First establishment Reek 86, Bornem

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 13 February 2015, DR. was incorporated.1 In 2017 the registered office moved to Bornem.2 Total assets went from €360,753 in 2018 to €536,650 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 21-02-2017
  3. 3National Bank, annual accounts 2018 and 2025

Company details

Identity

Enterprise number
0597.967.683
VAT number
BE 0597.967.683
Peppol ID
0208:0597967683
Other Peppol ID
9925:BE0597967683
Legal form
Private limited company
Status
Active, normal situation
Founded
13-02-2015
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Saturday of June at 10:00
deed of 08-12-2023 (in Dutch)
Peppol
Reachable since 09-01-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
DR. TOM BOGAERT in Dutch
Entity type
Legal entity
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 08-12-2023 (in Dutch)

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
Codes under NACEBEL 2008
86220 Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“De samenwerking met alle ondernemingen die een gelijkaardig voorwerp nastreven, maar overeenkomsten die geneesheren niet mogen afsluiten met…”
7 activities
  1. De samenwerking met alle ondernemingen die een gelijkaardig voorwerp nastreven, maar overeenkomsten die geneesheren niet mogen afsluiten met andere geneesheren of met derden, zullen ook door de vennootschap niet mogen afgesloten worden.
  2. Het inrichten en ter beschikking stellen van een medische bibliotheek en medische apparatuur.
  3. Het bevorderen en verwezenlijken van de medische studie, onder meer het bijwonen van colloquia en congressen, alsook de organisatie van seminaries, colloquia, cursussen, studiereizen en lessen in verband met de beroepsactiviteiten, het optreden als stagebegeleider, het schrijven en de publicatie van medische artikelen en boeken.
  4. De aankoop, het huren en/of leasen van alle medische apparatuur en begeleidende accommodaties, inclusief gebouwen, nodig of nuttig in het kader van de uitoefening van voormelde activiteit.
  5. De deelname in kostenassociaties of middelenvennootschappen van geneesheren.
  6. Lid worden van een vereniging zonder winstgevend doel van geneesheren.
  7. De uitoefening van de geneeskunde met specialisatie ANESTHESIE en PIJNTHERAPIE door de arts-aandeelhouder, met inachtname van de regels van de Medische Plichtenleer, onder meer met betrekking tot het beroepsgeheim.
deed of 08-12-2023 (in Dutch)

Registered office and establishments

1 establishment
Establishment Since Unit number
Reek 86 registered office 2880 Bornem 13-02-2015 2.239.417.917
1 former office
  • Dorpsstraat 24 bus 7, 8340 Damme until 01-10-2016 · deed of 21-02-2017

Buildings and parcels at the address

Ground area
3,415 m²
Buildings
320 m²
Volume, LiDAR
2,104 m³
Tallest building
11.5 m
Buildings to scale, each on its own parcel
320 m², 11.5 m 320 m², 11.5 m

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
12007A0119/00C0023,415 m² 1 · 320 m² 11.5 m · 2

We would like to set cookies. That happens only with your consent. What we measure